NCT02995863

Brief Summary

This research presents a randomized clinical trial which analyzes the efficacy of a rigid rocker sole in the reduction of the recurrence rate of plantar ulcers in diabetic foot patients. The hypothesis of the research is the use of a rigid rocker sole reduces the recurrence rate of diabetic foot ulcers in patients with peripheral neuropathy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 10, 2016

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

December 12, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 19, 2016

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2017

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2018

Completed
Last Updated

May 16, 2018

Status Verified

May 1, 2018

Enrollment Period

1 year

First QC Date

December 12, 2016

Last Update Submit

May 10, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Presence of diabetic foot ulcer

    The Wagner system assesses ulcer depth and the presence of osteomyelitis or gangrene using the following grades: grade 0 (pre- or post-ulcerative lesion), grade 1 (partial/full-thickness ulcer), grade 2 (probing to tendon or capsule), grade 3 (deep with osteitis), grade 4 (partial foot gangrene) and grade 5 (whole foot gangrene

    through study completion, an average of 6 months

Secondary Outcomes (10)

  • Ankle Joint movility

    through study completion, an average of 6 months

  • Mobility of the First metatarsal Joint

    through study completion, an average of 6 months

  • Subtalar Joint Movements

    through study completion, an average of 6 months

  • IPAQ (International Physical Activity Questionnaires)

    through study completion, an average of 6 months

  • Foot Type

    through study completion, an average of 6 months

  • +5 more secondary outcomes

Study Arms (2)

Experimental Group

EXPERIMENTAL

Rigid rocker sole footwear

Device: Rigid Rocker Sole Footwear

Control Group

ACTIVE COMPARATOR

Therapeutic footwear

Device: Therapeutic Footwear

Interventions

Experimental Group
Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type 1 or 2 diabetic patients regardless of the pharmacotherapy that they receive.
  • Adult patients of both sexes.
  • Peripheral neuropathy patients.
  • Patients without wounds or ulcers at the examination time.
  • Patients with a foot ulcers history.
  • Patients who don´t need gait support mechanisms such as walking sticks, crutches, splints or any other devices which interferes with the autonomous development of the gait.

You may not qualify if:

  • Patients with mayor amputation.
  • Patients with rheumatic disease that affect the feet.
  • Patients with peripheral neuropathy of different etiology to Diabetes mellitus.
  • Patients with several critical ischemia criteria, defined by TACS II guideline.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clínica Universitaria de Podología de la Universidad Complutense de Madrid

Madrid, 28040, Spain

Location

Related Publications (1)

  • Lopez-Moral M, Lazaro-Martinez JL, Garcia-Morales E, Garcia-Alvarez Y, Alvaro-Afonso FJ, Molines-Barroso RJ. Clinical efficacy of therapeutic footwear with a rigid rocker sole in the prevention of recurrence in patients with diabetes mellitus and diabetic polineuropathy: A randomized clinical trial. PLoS One. 2019 Jul 11;14(7):e0219537. doi: 10.1371/journal.pone.0219537. eCollection 2019.

MeSH Terms

Conditions

Diabetic Foot

Condition Hierarchy (Ancestors)

Diabetic AngiopathiesVascular DiseasesCardiovascular DiseasesFoot UlcerLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesDiabetic Neuropathies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Research

Study Record Dates

First Submitted

December 12, 2016

First Posted

December 19, 2016

Study Start

December 10, 2016

Primary Completion

December 10, 2017

Study Completion

May 10, 2018

Last Updated

May 16, 2018

Record last verified: 2018-05

Locations